ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ABC Abcam Plc

1,226.00
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,226.00 1,240.00 1,246.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Abcam Share Discussion Threads

Showing 726 to 750 of 1525 messages
Chat Pages: Latest  37  36  35  34  33  32  31  30  29  28  27  26  Older
DateSubjectAuthorDiscuss
21/11/2014
20:25
Now shipped 140k products in last 90 days, up from 130k - probably explains today's rise.
trident5
21/11/2014
10:53
Chart starting to turn up, director changes, directors buying.

Setting up for a rally here?

CR

cockneyrebel
03/11/2014
10:27
ABCAM Plc AGM Statement
Print
Alert
TIDMABC

RNS Number : 8840V

ABCAM Plc

03 November 2014

For immediate release 3 November 2014

ABCAM PLC

("Abcam" or "the Company")

AGM Statement

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is holding its Annual General Meeting this morning.

At the meeting Michael Redmond, Abcam's outgoing Chairman, will make the following statement:

"As previously announced, trading in the 2014/15 financial year has started well. The positive momentum we saw in the second half of our last financial year is continuing, as we invest in new products and capabilities, and increase our geographic penetration.

The Board believes that Abcam is well positioned to deliver continued growth and to meet its financial and strategic objectives for the year."

ranger101
27/8/2014
10:17
I have a small holding in SRT, will increase on order news.
Luck
apad

apad
27/8/2014
09:08
My largest is more speculative APAD - it's SRT. Revenue wise it's
still a bit blue sky/jam tomorrow, but it looks positioned to be
the global market leader if AIS takes off.

trident5
27/8/2014
08:55
ABC just overhauled by TRCS trid. so 2nd as well.
This must be an omen:-)
What's your largest?
apad

apad
26/8/2014
21:38
That's a coincidence Apad - Kentz was my 2nd biggest holding
too.

Now Abcam is. I hope this does half as well as Kentz.

trident5
26/8/2014
21:10
Now my biggest holding since KENZ got taken out, rich.
1 May 2014: 131276 antibodies, last 90 days 13000 products to 83
countries, 26 vacancies
1 July 2014: 133073 antibodies, last 90 days 13000 products to 89
countries, 34 vacancies
21 Aug 2014: 134552 antibodies, last 90 days 13000 products to 89
countries, 39 vacancies
apad

apad
26/8/2014
20:42
Chart doesn't look too bad....
richscotsman
19/8/2014
13:46
That's the kiss of death, then.
trident5
19/8/2014
13:19
G.Sachs start coverage today with a buy.

Results early Sep

CR

cockneyrebel
12/8/2014
23:09
Good to see continuous improvement to help reduce overheads and grow market share....

CAMBRIDGE, England--(BUSINESS WIRE)--Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam's focus on providing the best products and services to accelerate the pace of researchers' scientific discoveries.

The new service enables customers in Australia and New Zealand to order their research tools directly from Abcam rather than through a distributor. These customers will also benefit from direct technical support, and delivery times reduced by up to 50% from order to delivery.

richscotsman
24/7/2014
16:26
happy days... decent profit growth with currency movement and double digit when that it stripped out. China sales whilst still very small could start to contribute more strongly in the next few years as well.

Apad - we both increased too soon but not too late!

Rich

richscotsman
23/7/2014
08:55
that's good - the question is, will we break through 400 (and stay there)?
artibee
23/7/2014
08:52
Tempus column in The Times today has a good piece on ABCAM rating them a Buy as shares have fallen a long way and recovery looks set with 10.6% growth in second-half revenues.
rvsy38
18/7/2014
08:21
I guess government spending + currencies + increased spending on headcount, rich.
I increased too soon.
apad

apad
14/7/2014
23:00
Trading update soon.... There are headwinds re currencies but I hope this has been written down too much... A week or two and we should be a bit more informed....
richscotsman
02/7/2014
14:10
Lots of new jobs in the states.... Bodes well....
richscotsman
01/7/2014
08:18
1 May 2014: 131276 antibodies, last 90 days 130000 products to 83 countries, 26 vacancies
1 July 2014: 133073 antibodies, last 90 days 130000 products to 89 countries, 34 vacancies

apad

apad
20/5/2014
18:35
Thanks simon... I am going to start loading up my sipp at this price!
richscotsman
20/5/2014
07:56
Unicorn AIM VCT - 20/5/14

Abcam (-23%) is a global leader in the supply of innovative protein research tools. In March 2014, Abcam released its financial results for the six month period ended 31 December 2013, which were in line with your Investment Manager's internal forecasts. Revenues of £61.9m (H2 2012: £57.3m) represented half-year on half-year growth of over 8%, while earnings per share were up 6.5% to 8.74p (H2 2012: 8.21p). Abcam remains a cash generative business with a robust balance sheet. Net cash balances at the period end amounted to £35.3m. Despite Abcam's many obvious qualities, market reaction to the release of Interim Results in early March was negative as investors worried about currency headwinds and the impact of possible cuts to health budgets in the key North American market, which accounts for 43% of total sales. As a result, Abcam's share price ended the period markedly lower. The holding has been retained in the portfolio in the expectation that the de-rating in the value of Abcam will prove to be temporary.

simon gordon
06/5/2014
20:33
It's kind of bowly and sitting at the bottom of an egg, that pointy bit pointing downwards - is that the beak?
trident5
06/5/2014
20:06
Next leg up starting?

Nice bowly sort of chart imo.

cockneyrebel
06/5/2014
20:02
Chart looks okay... Struggling against string dollar but slowly and surely we are coming back to the long term trend...
richscotsman
02/5/2014
08:10
Looking strong today.
scrabble1975
Chat Pages: Latest  37  36  35  34  33  32  31  30  29  28  27  26  Older

Your Recent History

Delayed Upgrade Clock